[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Bell et al., 2002 - Google Patents

Refolding and structural characterization of the human p53 tumor suppressor protein

Bell et al., 2002

Document ID
14738453219071250502
Author
Bell S
Hansen S
Buchner J
Publication year
Publication venue
Biophysical chemistry

External Links

Snippet

The human tumor suppressor p53 is a conformationally flexible and functionally complex protein that is only partially understood on a structural level. We expressed full-length p53 in the cytosol of Escherichia coli as inclusion bodies. To obtain active, recombinant p53, we …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members

Similar Documents

Publication Publication Date Title
Bell et al. Refolding and structural characterization of the human p53 tumor suppressor protein
Bell et al. p53 contains large unstructured regions in its native state
Weinberg et al. Cooperative binding of tetrameric p53 to DNA
Hansen et al. Allosteric regulation of the thermostability and DNA binding activity of human p53 by specific interacting proteins
Lacy et al. Molecular basis for the specificity of p27 toward cyclin-dependent kinases that regulate cell division
Selivanova et al. Reactivation of mutant p53 through interaction of a C-terminal peptide with the core domain
Bargonetti et al. A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein.
Sumida et al. Conserved Asp-137 imparts flexibility to tropomyosin and affects function
Hupp Regulation of p53 protein function through alterations in protein-folding pathways
Rao et al. Design and expression of peptide antibiotic hPAB-β as tandem multimers in Escherichia coli
Hagemann et al. Selectional and mutational scope of peptides sequestering the Jun–Fos coiled-coil domain
Cingolani et al. Nuclear import factors importin α and importin β undergo mutually induced conformational changes upon association
Andrau et al. Mutagenesis of yeast TFIIIB70 reveals C-terminal residues critical for interaction with TBP and C34
Hollenbeck et al. GCN4 binds with high affinity to DNA sequences containing a single consensus half-site
Quinternet et al. Structure/function analysis of protein–protein interactions developed by the Yeast Pih1 platform protein and its partners in Box C/D snoRNP Assembly
Shirakata et al. Dimerization specificity of myogenic helix-loop-helix DNA-binding factors directed by nonconserved hydrophilic residues.
Juichi et al. Chemical synthesis of a two‐domain scorpion toxin LaIT2 and its single‐domain analogs to elucidate structural factors important for insecticidal and antimicrobial activities
Carneiro et al. Spectroscopic characterization of the tumor antigen NY-REN-21 and identification of heterodimer formation with SCAND1
Matsubara et al. MARCKS, a major protein kinase C substrate, assumes non-helical conformations both in solution and in complex with Ca2+-calmodulin
Dengler et al. Display Selection of a Hybrid Foldamer–Peptide Macrocycle
McCormack et al. Yeast phosducin-like protein 2 acts as a stimulatory co-factor for the folding of actin by the chaperonin CCT via a ternary complex
Burch et al. Expansion of protein interaction maps by phage peptide display using MDM2 as a prototypical conformationally flexible target protein
Hyland et al. The DNA binding domain of the gene 2.5 single-stranded DNA-binding protein of bacteriophage T7
Liu et al. Protein–protein interactions among human lens acidic and basic β-crystallins
Poon et al. Tandem dimerization of the human p53 tetramerization domain stabilizes a primary dimer intermediate and dramatically enhances its oligomeric stability